Alzheimer; News from the web:
The hope that Alzheimer’s will one day be curable has in recent yearsfaded to a flicker as successive clinical trials ended in failure. But the prospect of a treatment this week grew a little brighter as scientists uncovered a new and unexpected explanation for the development of the disease.
Read all about it HERE
Alzheimer; News from the web:
Pippa Kelly made me aware of the great work the Life Story Network does.
Discovering George Arthur Moss through his Life Story Book reminded me that we are all so much more than the aspect we present to a stranger for the very first time. When we’re independent and can communicate clearly, this doesn’t much matter, but if and when our health fails or for some reason we become dependent on others, it is vital for them to know who we are. Of course it is. Put like that, it sounds so obvious, so simple, so human.
Read all about the Life Story Network HERE Pippa’s blog is HERE
Alzheimer; News from the web:
HERE is a great initiative!
“Once you get the diagnosis [of Alzheimer’s], you’re identified as either the patient or the caregiver. You start to feel less like spouses,” said Tom Allen, who takes a half-day of vacation on Wednesdays so he can attend the rehearsals at the MacPhail Center for Music in downtown Minneapolis. “In this environment, we’re husband and wife. This is one of the few things that we can still do as a couple. … We love this choir.”
Read all about it HERE
Alzheimer; News from the web:
Another article about the claimed miracle diet to prevent Alzheimer called DASH. This time a more practical guide with what foods to eat and to avoid and what to make for dinner.
Read all about it HERE
Alzheimer; News from the web:
More news on the great trial from Biogen:
A new Alzheimer’s drug that reverses the damage the disease causes in patients’ brains could ‘change the landscape’ of future treatment, according to researchers.
It has already performed so well at early-stage trials involving people living with the disease in the United States that scientists are now in talks aimed at leapfrogging the usual second stage and fast-tracking it for larger trials.
Pharmaceutical firm Biogen, which developed the drug, called aduncanumab, wants to recruit at least 1,000 patients for tests by the end of the year.
Read all about it HERE
Alzheimer; News from the web:
A new large study by the Mayo clinic points at Tau being the dominant factor in causing Alzheimer. This research will be very beneficial in finding new ways for both prevention and treatment.
Read all about it HERE